Clinical Scorecard: Safety and Efficacy of Small Particle Bronchial Artery Embolization: Insights from a 12-Year Single-Center Study

At a Glance

Key Highlights

• Use of small PVA particles (150–250 µm) for embolization may achieve more distal embolization and better outcomes in persistent or recurrent hemoptysis
• Technical success defined as catheterization and embolization of all hypertrophied bronchial and non-bronchial systemic arteries
• Clinical success defined as cessation or significant reduction of hemoptysis without need for further intervention within 30 days

Guideline-Based Recommendations

Diagnosis

• Perform aortic-phase contrast-enhanced CT pre-procedure to identify bleeding site, evaluate artery hypertrophy, and detect pulmonary artery pseudoaneurysms
• Exclude patients with hemoptysis due to pulmonary artery aneurysmal disease without bronchial artery hypertrophy

Management

• Optimize respiratory function, clotting, and hemodynamics prior to procedure
• Administer tranexamic acid and antimicrobials when appropriate
• Perform angiography via femoral arterial approach with selective and super-selective catheterization
• Use 150–250 µm PVA particles as initial embolic agent; larger particles up to 1000 µm may be used subsequently
• For pulmonary artery pseudoaneurysms, perform front door/backdoor embolization with microcoils or vascular plugs before systemic arterial embolization

Monitoring & Follow-up

• Confirm vessel occlusion and obliteration of systemic-to-pulmonary artery shunting by post-embolization angiography
• Monitor for clinical improvement and absence of hemoptysis recurrence within 30 days

Risks

• Major complications include those requiring unplanned treatment, prolonged hospitalization, permanent adverse sequelae, or death
• Minor complications are self-limiting and require no specific treatment
• Use of particles smaller than 300 µm is considered safe by authors despite prevailing opinions favoring larger particles to reduce non-target embolization

Patient & Prescribing Data

Patients with massive hemoptysis (>300 mL/24 h) or recurrent less severe bleeding not responsive to conservative treatment

Small particle embolization with 150–250 µm PVA particles is effective and safe for controlling hemoptysis and may reduce recurrence

Clinical Best Practices

• Obtain informed consent and optimize patient condition prior to embolization
• Use pre-procedural CT imaging to guide embolization strategy
• Perform embolization distal to important branches to avoid non-target embolization
• Confirm technical success with angiographic evidence of vessel occlusion
• Provide anesthetic support as needed during procedure

References

• Reference 1
• Reference 2
• Reference 3
• Reference 4
• Reference 5
• Reference 6
• Reference 7
• Reference 8
• Reference 9
• Reference 10
• Reference 11
• Reference 12
• Reference 13
• Reference 14
• Reference 15
• Reference 16
• Reference 17